The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic …

R Acevedo, X Bai, R Borrow, DA Caugant… - Expert review of …, 2019 - Taylor & Francis
ABSTRACT Introduction: The 2018 Global Meningococcal Initiative (GMI) meeting focused
on evolving invasive meningococcal disease (IMD) epidemiology, surveillance, and …

Global practices of meningococcal vaccine use and impact on invasive disease

A Ali, RZ Jafri, N Messonnier… - … and Global Health, 2014 - Taylor & Francis
A number of countries now include meningococcal vaccines in their routine immunization
programs. This review focuses on different approaches to including meningococcal vaccines …

First use of a serogroup B meningococcal vaccine in the US in response to a university outbreak

LA McNamara, AM Shumate, P Johnsen… - …, 2015 - publications.aap.org
BACKGROUND: In 2013–2014, an outbreak of serogroup B meningococcal disease
occurred among persons linked to a New Jersey university (University A). In the absence of …

[HTML][HTML] Cuban meningococcal vaccine VA-MENGOC-BC: 30 years of use and future potential

VG Sierra-González - MEDICC review, 2019 - SciELO Public Health
Every year, meningococcal infection by Neisseria meningitidis causes over 500,000 cases
and 85,000 deaths in the world, with 20% of survivors suffering sequelae. In Cuba its …

Carriage of Neisseria Meningitidis in Low and Middle Income Countries of the Americas and Asia: A Review of the Literature

L Serra, J Presa, H Christensen, C Trotter - Infectious diseases and …, 2020 - Springer
Introduction Meningococcal colonization, or carriage, can progress to invasive
meningococcal disease, a serious public health concern, with rapid progression of disease …

VA-MENGOC-BC vaccination induces serum and mucosal anti Neisseria gonorrhoeae immune responses and reduces the incidence of gonorrhea

LMR Díaz, MSJBL González, M Cuello… - The Pediatric …, 2021 - journals.lww.com
Background: Overall, there are over 30 different sexually transmitted infections with
Neisseria gonorrhoeae being the third most frequent with a reported 78 million cases per …

Cross-protection induced by VA-MENGOC-BC® vaccine

RF Ochoa-Azze - Human vaccines & immunotherapeutics, 2018 - Taylor & Francis
ABSTRACT I would like to comment on the article “Commentary: Impact of meningococcal
group B OMV vaccines, beyond their brief”, DOI: 10.1080/21645515.2017. 1381810. The …

Broad vaccine protection against Neisseria meningitidis using factor H binding protein

J Findlow, CD Bayliss, PT Beernink, R Borrow… - Vaccine, 2020 - Elsevier
Neisseria meningitidis, the causative agent of invasive meningococcal disease (IMD), is
classified into different serogroups defined by their polysaccharide capsules. Meningococcal …

Distribution of serogroups and sequence types in disease-associated and carrier strains of Neisseria meningitidis isolated in China between 2003 and 2008

H Zhou, Y Gao, L Xu, M Li, Q Li, Y Li, X Liang… - Epidemiology & …, 2012 - cambridge.org
Given the unpredictability of Neisseria meningitidis outbreaks and the increased prevalence
of serogroup C strains following the introduction of serogroup A-based vaccines, we …

Characterization of Carriage Isolates of Neisseria meningitidis in the Adolescents and Young Adults Population of Bogota (Colombia)

J Moreno, M Hidalgo, C Duarte, O Sanabria… - PLoS …, 2015 - journals.plos.org
Background Meningococcal carriage studies are important to improve our understanding of
the epidemiology of meningococcal disease. The aim of this study was to determine the …